top of page
  • Writer's pictureA2A Pharma

A2A Finalist

Updated: Feb 7, 2020

A2A was a finalist at RESI NYC tech hub pitch challenge


42 views0 comments

Recent Posts

See All

Biomea Fusion, Inc., a precision oncology company dedicated to developing innovative medicines targeting genomically defined alterations in both hematologic and solid cancers, announced the closing of

Dr. Siddhartha Mukherjee, Dr. Annalisa Jenkins and Dr. Srikumar Chellappan join A2A’s Advisory Board. LEARN MORE

bottom of page